About the Company
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ACOR News
ACORQ Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral ...
Acorda: Q1 Earnings Snapshot
PEARL RIVER, N.Y. — PEARL RIVER, N.Y. — Acorda Therapeutics Inc. (ACORQ) on Tuesday reported a loss of $27.4 million in its first quarter. On a per-share basis, the Pearl River, New York-based company ...
Acorda Stock Gaps Up On Today's Open (ACOR)
Acorda Therapeutics, Inc., a biotechnology company, develops therapies for multiple sclerosis, spinal cord injury, and other nervous system disorders.
Global Formulation Development Outsourcing Industry
Global Formulation Development Outsourcing Industry is expected to reach US$ 66.6 Billion in 2032, likely to surge at a vigorous 7.2% CAGR ...
Acorda Therapeutics
HQ location Ardsley, N.Y. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA ...
Acorda Therapeutics Announces Delisting from Nasdaq
PEARL RIVER, N.Y., April 15, 2024--(BUSINESS WIRE)--Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the ...
Acorda Therapeutics, Inc. Common Stock (ACOR)
NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...
Acorda Therapeutics Inc ACORQ
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Acorda Therapeutics, Inc. Common Stock (ACOR)
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Acorda Therapeutics, Inc. (ACORQ)
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Loading the latest forecasts...